Level Biotechnology Inc. (TPEX:3118)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
33.45
-0.05 (-0.15%)
Mar 4, 2026, 1:28 PM CST

Level Biotechnology Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
79.764.8162.9158.4768.18
Depreciation & Amortization
22.4621.2219.7219.519.79
Loss (Gain) From Sale of Assets
0-0.02-0.1-0.080.13
Loss (Gain) From Sale of Investments
-8.22----
Provision & Write-off of Bad Debts
-0.03-0.060.24--
Other Operating Activities
1.19-0.192-3.71.37
Change in Accounts Receivable
-42.71-26.5-22.9856.35
Change in Inventory
-17.51-9.24-15.39-17.537.36
Change in Accounts Payable
14.772.55-14.817.36-25.79
Change in Unearned Revenue
0.93-1.113.2123.0418.53
Change in Other Net Operating Assets
9.04-11.865.91-910.03
Operating Cash Flow
59.6164.170.2165.07155.95
Operating Cash Flow Growth
-7.00%-8.71%7.90%-58.27%87.38%
Capital Expenditures
-32.67-223.68-7.67-6.74-9.16
Sale of Property, Plant & Equipment
-0.030.230.15-
Investment in Securities
-2.18----
Other Investing Activities
-4.097.54-3.46-3.60.37
Investing Cash Flow
-38.93-216.11-10.9-10.19-8.79
Long-Term Debt Repaid
-4.7-4.57-3.12-2.69-2.66
Net Debt Issued (Repaid)
-4.7-4.57-3.12-2.69-2.66
Common Dividends Paid
-58.42-55.17-55.17-61.66-51.93
Other Financing Activities
--2.882.88-0.06
Financing Cash Flow
-63.12-62.62-55.4-64.35-54.52
Net Cash Flow
-42.44-214.623.91-9.4692.64
Free Cash Flow
26.94-159.5862.5458.33146.8
Free Cash Flow Growth
--7.22%-60.26%81.93%
Free Cash Flow Margin
3.66%-21.82%9.47%9.84%21.67%
Free Cash Flow Per Share
0.82-4.891.921.794.49
Cash Interest Paid
0.20.280.330.350.38
Cash Income Tax Paid
16.6116.2613.7417.9115.35
Levered Free Cash Flow
6.06-175.0840.740.94127.71
Unlevered Free Cash Flow
6.19-174.940.9141.15127.95
Change in Working Capital
-35.48-21.66-14.56-9.1166.48
Source: S&P Global Market Intelligence. Standard template. Financial Sources.